| UniProt ID | CLCA_HUMAN | |
|---|---|---|
| UniProt AC | P09496 | |
| Protein Name | Clathrin light chain A | |
| Gene Name | CLTA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 248 | |
| Subcellular Localization |
Cytoplasmic vesicle membrane Peripheral membrane protein Cytoplasmic side. Membrane, coated pit Peripheral membrane protein Cytoplasmic side. Cytoplasm, cytoskeleton, spindle . Cytoplasmic face of coated pits and vesicles. In complex with TACC3 a |
|
| Protein Description | Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. [PubMed: 15858577] | |
| Protein Sequence | MAELDPFGAPAGAPGGPALGNGVAGAGEEDPAAAFLAQQESEIAGIENDEAFAILDGGAPGPQPHGEPPGGPDAVDGVMNGEYYQESNGPTDSYAAISQVDRLQSEPESIRKWREEQMERLEALDANSRKQEAEWKEKAIKELEEWYARQDEQLQKTKANNRVADEAFYKQPFADVIGYVTNINHPCYSLEQAAEEAFVNDIDESSPGTEWERVARLCDFNPKSSKQAKDVSRMRSVLISLKQAPLVH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 83 | Phosphorylation | DGVMNGEYYQESNGP CCCCCCCEEHHHCCC | 16.31 | 22817900 | |
| 84 | Phosphorylation | GVMNGEYYQESNGPT CCCCCCEEHHHCCCC | 11.08 | 22817900 | |
| 87 | Phosphorylation | NGEYYQESNGPTDSY CCCEEHHHCCCCCHH | 31.40 | 24275569 | |
| 91 | Phosphorylation | YQESNGPTDSYAAIS EHHHCCCCCHHHHHH | 38.69 | - | |
| 93 | Phosphorylation | ESNGPTDSYAAISQV HHCCCCCHHHHHHHH | 21.10 | 24275569 | |
| 94 | Phosphorylation | SNGPTDSYAAISQVD HCCCCCHHHHHHHHH | 11.67 | 22817900 | |
| 105 (in isoform 2) | Phosphorylation | - | 60.76 | 24719451 | |
| 105 (in isoform 3) | Phosphorylation | - | 60.76 | - | |
| 105 | Phosphorylation | SQVDRLQSEPESIRK HHHHHHHCCCHHHHH | 60.76 | 19664994 | |
| 109 | Phosphorylation | RLQSEPESIRKWREE HHHCCCHHHHHHHHH | 38.11 | 22167270 | |
| 109 (in isoform 2) | Phosphorylation | - | 38.11 | 21406692 | |
| 109 (in isoform 3) | Phosphorylation | - | 38.11 | - | |
| 118 | Sulfoxidation | RKWREEQMERLEALD HHHHHHHHHHHHHHC | 3.51 | 30846556 | |
| 123 (in isoform 5) | Phosphorylation | - | 18.48 | 29116813 | |
| 124 (in isoform 5) | Phosphorylation | - | 4.70 | 25849741 | |
| 127 (in isoform 5) | Phosphorylation | - | 41.85 | 29514088 | |
| 128 | Phosphorylation | LEALDANSRKQEAEW HHHHCHHHHHHHHHH | 42.44 | 21712546 | |
| 130 | Ubiquitination | ALDANSRKQEAEWKE HHCHHHHHHHHHHHH | 52.92 | - | |
| 141 (in isoform 1) | Ubiquitination | - | 62.19 | 21890473 | |
| 141 | Ubiquitination | EWKEKAIKELEEWYA HHHHHHHHHHHHHHH | 62.19 | 21890473 | |
| 141 | 2-Hydroxyisobutyrylation | EWKEKAIKELEEWYA HHHHHHHHHHHHHHH | 62.19 | - | |
| 141 (in isoform 2) | Ubiquitination | - | 62.19 | 21890473 | |
| 141 (in isoform 3) | Ubiquitination | - | 62.19 | 21890473 | |
| 141 | Ubiquitination | EWKEKAIKELEEWYA HHHHHHHHHHHHHHH | 62.19 | 21890473 | |
| 147 | Phosphorylation | IKELEEWYARQDEQL HHHHHHHHHHHHHHH | 8.66 | 28796482 | |
| 156 | Acetylation | RQDEQLQKTKANNRV HHHHHHHHHHHHCHH | 61.66 | 25953088 | |
| 156 | Ubiquitination | RQDEQLQKTKANNRV HHHHHHHHHHHHCHH | 61.66 | - | |
| 175 (in isoform 2) | Phosphorylation | - | 32.71 | 29116813 | |
| 176 (in isoform 2) | Phosphorylation | - | 3.07 | 25849741 | |
| 179 (in isoform 2) | Phosphorylation | - | 7.93 | 29514088 | |
| 194 (in isoform 3) | Phosphorylation | - | 18.17 | - | |
| 205 | Phosphorylation | FVNDIDESSPGTEWE HHHCCCCCCCCCHHH | 37.78 | 22167270 | |
| 206 (in isoform 2) | Phosphorylation | - | 25.87 | - | |
| 206 | Phosphorylation | VNDIDESSPGTEWER HHCCCCCCCCCHHHH | 25.87 | 22167270 | |
| 209 | Phosphorylation | IDESSPGTEWERVAR CCCCCCCCHHHHHHH | 41.11 | 22167270 | |
| 212 (in isoform 2) | Ubiquitination | - | 30.92 | - | |
| 223 | Acetylation | RLCDFNPKSSKQAKD HHHCCCCCCCHHHHH | 69.35 | 26051181 | |
| 223 | Malonylation | RLCDFNPKSSKQAKD HHHCCCCCCCHHHHH | 69.35 | 26320211 | |
| 223 | 2-Hydroxyisobutyrylation | RLCDFNPKSSKQAKD HHHCCCCCCCHHHHH | 69.35 | - | |
| 223 | Methylation | RLCDFNPKSSKQAKD HHHCCCCCCCHHHHH | 69.35 | - | |
| 223 | Ubiquitination | RLCDFNPKSSKQAKD HHHCCCCCCCHHHHH | 69.35 | - | |
| 224 | Phosphorylation | LCDFNPKSSKQAKDV HHCCCCCCCHHHHHH | 43.98 | 18691976 | |
| 224 (in isoform 3) | Phosphorylation | - | 43.98 | - | |
| 226 | Ubiquitination | DFNPKSSKQAKDVSR CCCCCCCHHHHHHHH | 62.46 | - | |
| 226 | Methylation | DFNPKSSKQAKDVSR CCCCCCCHHHHHHHH | 62.46 | - | |
| 232 | Phosphorylation | SKQAKDVSRMRSVLI CHHHHHHHHHHHHHH | 30.41 | 29514088 | |
| 236 | Phosphorylation | KDVSRMRSVLISLKQ HHHHHHHHHHHHHHH | 16.36 | 23911959 | |
| 240 | Phosphorylation | RMRSVLISLKQAPLV HHHHHHHHHHHCCCC | 25.92 | 23403867 | |
| 242 | 2-Hydroxyisobutyrylation | RSVLISLKQAPLVH- HHHHHHHHHCCCCC- | 37.31 | - | |
| 242 | Acetylation | RSVLISLKQAPLVH- HHHHHHHHHCCCCC- | 37.31 | 23954790 | |
| 242 | Malonylation | RSVLISLKQAPLVH- HHHHHHHHHCCCCC- | 37.31 | 26320211 | |
| 242 | Ubiquitination | RSVLISLKQAPLVH- HHHHHHHHHCCCCC- | 37.31 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLCA_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLCA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLCA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HSP7C_HUMAN | HSPA8 | physical | 1975516 | |
| MD2L2_HUMAN | MAD2L2 | physical | 21152103 | |
| TERA_HUMAN | VCP | physical | 8413590 | |
| RGS2_HUMAN | RGS2 | physical | 21988832 | |
| CLH1_HUMAN | CLTC | physical | 26344197 | |
| CLH2_HUMAN | CLTCL1 | physical | 26344197 | |
| DP13A_HUMAN | APPL1 | physical | 27173435 | |
| CLCB_HUMAN | CLTB | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206 AND SER-236, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; SER-206 ANDSER-236, AND MASS SPECTROMETRY. | |